Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Coronavirus

It has been previously estimated that the risk of venal thrombosis (VTE) among people hospitalised with COVID-19 is around 9% while the risk of an or arterial thrombosis (ATE) is 4%. However, little data exists for these events in patients who have not been admitted to hospital.

A new study published in the Lancet Infectious Diseases, estimates the incidence of VTE and ATE among almost 1 million people with COVID-19, using routinely collected data from across Europe. The study found that for people with COVID-19, the risks ranged from 0.2% to 0.8% for VTE. For ATE it was from 0.1% to 0.8%.

Incidence of these events increased to 4.5% and 3.1% for those hospitalised with COVID-19. Meanwhile, 90-day mortality was between 1.1% and 2.0% among COVID-19 cases and increased to 14.6% for those hospitalised.
Results also showed that being male was generally associated with an increased risk of VTE, ATE, and death, as were various comorbidities and prior medications.

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences website.